Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer. Reply
- PMID: 32101674
- DOI: 10.1056/NEJMc1916859
Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer. Reply
Comment on
-
Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer.N Engl J Med. 2020 Feb 27;382(9):874. doi: 10.1056/NEJMc1916859. N Engl J Med. 2020. PMID: 32101672 No abstract available.
-
Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer.N Engl J Med. 2020 Feb 27;382(9):874-875. doi: 10.1056/NEJMc1916859. N Engl J Med. 2020. PMID: 32101673 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical